KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2021 | |
|---|---|---|---|---|
| Revenue | $59,815 | $27,814 | $7,630 | $0 |
| % Growth | 115.1% | 264.5% | – | – |
| Cost of Goods Sold | $35,605 | $27,452 | $18,281 | $0 |
| Gross Profit | $24,210 | $362 | -$10,651 | $0 |
| % Margin | 40.5% | 1.3% | -139.6% | – |
| R&D Expenses | $15,652 | $15,490 | $15,756 | $18,806 |
| G&A Expenses | $0 | $29,253 | $19,095 | $0 |
| SG&A Expenses | $114,936 | $69,935 | $54,014 | $13,902 |
| Sales & Mktg Exp. | $0 | $40,682 | $34,919 | $13,902 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $130,588 | $85,425 | $69,770 | $32,708 |
| Operating Income | -$106,378 | -$85,063 | -$80,421 | -$32,708 |
| % Margin | -177.8% | -305.8% | -1,054% | – |
| Other Income/Exp. Net | -$7,301 | -$9,033 | -$3,802 | -$1,206 |
| Pre-Tax Income | -$113,679 | -$94,096 | -$84,223 | -$33,914 |
| Tax Expense | $135 | $24 | $15 | $187 |
| Net Income | -$113,814 | -$94,120 | -$84,238 | -$34,101 |
| % Margin | -190.3% | -338.4% | -1,104% | – |
| EPS | -5.13 | -2.04 | -1.75 | -0.69 |
| % Growth | -151.5% | -16.6% | -153.6% | – |
| EPS Diluted | -5.13 | -2.04 | -1.75 | -0.69 |
| Weighted Avg Shares Out | 49,534 | 49,534 | 49,534 | 49,534 |
| Weighted Avg Shares Out Dil | 49,534 | 49,534 | 49,534 | 49,534 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,199 | $0 | $0 | $0 |
| Interest Expense | $7,734 | $6,230 | $5,629 | $1,168 |
| Depreciation & Amortization | $7,968 | $11,560 | $4,855 | $420 |
| EBITDA | -$97,977 | -$76,306 | -$73,739 | -$32,326 |
| % Margin | -163.8% | -274.3% | -966.4% | – |